CD1B and nasopharyngeal carcinoma: Regardless of the higher presentation capacity observed in NPC patients to present GM1 through CD1b, the same was not observed using the sulfatide-specific CD1b-restricted DS1C9b T cell clone (Figure 1F and Supplementary Figure 3B).